{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:00:08Z","timestamp":1793178008880,"version":"4.5.0"},"reference-count":118,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"accepted":{"date-parts":[[2026,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically synthesise the benefits and harms of add-on oral antihistamines for managing atopic dermatitis (eczema).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and network meta-analysis of randomised trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Medline, Embase, CENTRAL, the United States Food and Drug Administration, and the European Medicines Agency databases from database inception to 5 May 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study selection<\/jats:title>\n                    <jats:p>Randomised trials assessing add-on oral H1 antihistamines, H2 blockers, mast cell stabilisers (nedocromil sodium and sodium cromoglycate), or their combinations. Paired reviewers independently screened records, extracted data, and assessed risk of bias using a modified Cochrane Risk of Bias tool version 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Random effects bayesian meta-analyses synthesised atopic dermatitis severity (oSCORAD\u2014objective scoring atopic dermatitis, 0-83; minimal important difference 8.2; lower better), itch severity (numerical rating scale, 0-10; minimal important difference 3; lower better), sleep disturbance, atopic dermatitis related quality of life, and harms. The network meta-analysis GRADE (Grading of Recommendations Assessment, Development and Evaluation) and Core GRADE approaches informed certainty of evidence ratings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>47 trials enrolled 6230 children and adults with primarily moderate to severe atopic dermatitis. With moderate certainty, compared with placebo, adding a first generation or second generation H1 antihistamine likely resulted in a small reduction in atopic dermatitis severity (mean difference -1.87, 95% credible interval -3.47 to -0.27) and itch severity (-0.89, -1.41 to -0.37). Although statistically detectable, these effects are well below established minimal important differences (smallest change in an outcome that a patient would identify as important). With low certainty, all studied interventions may not improve sleep disturbance or reduce atopic dermatitis exacerbations. First generation agents probably increase cognitive impairment and may increase treatment discontinuation because of adverse events (risk difference 66 more per 1000, 95% credible interval 0 to 231 more; moderate certainty). Second generation agents differ in their risk of cognitive impairment (range of mean effects 0 more per 1000 for loratadine, 16 more per 1000 for levocetirizine, and 17 more per 1000 for cetirizine).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients with atopic dermatitis, adding H1 antihistamines probably results in a clinically unimportant reduction in atopic dermatitis severity and itch severity, and may not reduce sleep disturbance or atopic dermatitis exacerbations. First generation agents increase cognitive impairment and may increase treatment discontinuation because of adverse events. Cognitive impairment risk differs among second generation agents. These findings provide evidence against routine antihistamine use in atopic dermatitis management and will inform updated clinical guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      PROSPERO\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT42022345643\">NCT42022345643<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmj-2026-100163","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:36:47Z","timestamp":1785375407000},"page":"e100163","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Antihistamines for atopic dermatitis (eczema): systematic review and network meta-analysis of randomised trials"],"prefix":"10.1136","volume":"394","clinical-trial-number":[{"clinical-trial-number":"nct42022345643","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct42022345643","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00884325","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01840605","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00375713","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0201-2630","authenticated-orcid":true,"given":"Alexandro W L","family":"Chu","sequence":"first","affiliation":[{"name":"Evidence in Allergy Group, McMaster University, Hamilton, ON, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Wen","sequence":"additional","affiliation":[{"name":"Evidence in Allergy Group, McMaster University, Hamilton, ON, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Rao","sequence":"additional","affiliation":[{"name":"Evidence in Allergy Group, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Bakaa","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene X","family":"Zhao","sequence":"additional","affiliation":[{"name":"Evidence in Allergy Group, McMaster University, Hamilton, ON, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetiani","family":"Roldan","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M","family":"Spergel","sequence":"additional","affiliation":[{"name":"Division of Allergy-Immunology, Department of Pediatrics, Children\u2019s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"LeBovidge","sequence":"additional","affiliation":[{"name":"Division of Immunology, Boston Children\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boguniewicz","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine, Denver, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A","family":"Martin","sequence":"additional","affiliation":[{"name":"UMass Chan Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Laura","family":"Lind","sequence":"additional","affiliation":[{"name":"Patient author, School for Engineering of Matter, Transport and Energy, Arizona State University, Tempe, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Lio","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N","family":"Asiniwasis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Saskatchewan, Regina, SK, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York City, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Benedetto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Rochester Medical Center, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[{"name":"Asthma and Allergy Foundation of America, Arlington, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peck Y","family":"Ong","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Allergy, Children\u2019s Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfred T","family":"Frazier","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, UPMC St Margaret, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Nelson","sequence":"additional","affiliation":[{"name":"Patient author, Department of Health Sciences, Lakehead University, Thunder Bay, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Patient author, Tufts University School of Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korey","family":"Capozza","sequence":"additional","affiliation":[{"name":"Public representative, Global Parents for Eczema Research, Santa Barbara, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Smith","family":"Begolka","sequence":"additional","affiliation":[{"name":"Public representative, National Eczema Association, Novato, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna D","family":"Gardner","sequence":"additional","affiliation":[{"name":"Public representative, Allergy & Asthma Network, Fairfax, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda C","family":"Schneider","sequence":"additional","affiliation":[{"name":"Division of Immunology, Boston Children\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-4496","authenticated-orcid":true,"given":"Derek K","family":"Chu","sequence":"additional","affiliation":[{"name":"Evidence in Allergy Group, McMaster University, Hamilton, ON, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"},{"name":"The Research Institute of St Joe\u2019s Hamilton, St Joseph\u2019s Healthcare Hamilton, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2026072921050875000_394.jul29_5.e100163.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2017.10.039"},{"key":"2026072921050875000_394.jul29_5.e100163.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.11.009"},{"key":"2026072921050875000_394.jul29_5.e100163.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2007.00572.x"},{"key":"2026072921050875000_394.jul29_5.e100163.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.08.063"},{"key":"2026072921050875000_394.jul29_5.e100163.5","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14445"},{"key":"2026072921050875000_394.jul29_5.e100163.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.077"},{"key":"2026072921050875000_394.jul29_5.e100163.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2021.07.008"},{"key":"2026072921050875000_394.jul29_5.e100163.8","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13783"},{"key":"2026072921050875000_394.jul29_5.e100163.9","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14225"},{"key":"2026072921050875000_394.jul29_5.e100163.10","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00891-6"},{"key":"2026072921050875000_394.jul29_5.e100163.11","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-020-00114-x"},{"key":"2026072921050875000_394.jul29_5.e100163.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.07.105"},{"key":"2026072921050875000_394.jul29_5.e100163.13","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15728"},{"key":"2026072921050875000_394.jul29_5.e100163.14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4040741"},{"key":"2026072921050875000_394.jul29_5.e100163.15","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12032"},{"key":"2026072921050875000_394.jul29_5.e100163.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02519-4"},{"key":"2026072921050875000_394.jul29_5.e100163.17","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.201959"},{"key":"2026072921050875000_394.jul29_5.e100163.18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012167.pub2"},{"key":"2026072921050875000_394.jul29_5.e100163.19","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13609"},{"key":"2026072921050875000_394.jul29_5.e100163.20","unstructured":"Higgins JPT Thomas J Chandler J . Cochrane Handbook for Systematic Reviews of Interventions version 6.5: Cochrane, 2024."},{"key":"2026072921050875000_394.jul29_5.e100163.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2026072921050875000_394.jul29_5.e100163.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081903"},{"key":"2026072921050875000_394.jul29_5.e100163.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081904"},{"key":"2026072921050875000_394.jul29_5.e100163.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081905"},{"key":"2026072921050875000_394.jul29_5.e100163.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083864"},{"key":"2026072921050875000_394.jul29_5.e100163.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083865"},{"key":"2026072921050875000_394.jul29_5.e100163.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083866"},{"key":"2026072921050875000_394.jul29_5.e100163.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083867"},{"key":"2026072921050875000_394.jul29_5.e100163.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.03.024"},{"key":"2026072921050875000_394.jul29_5.e100163.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.08.029"},{"key":"2026072921050875000_394.jul29_5.e100163.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.08.030"},{"key":"2026072921050875000_394.jul29_5.e100163.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.06.044"},{"key":"2026072921050875000_394.jul29_5.e100163.33","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2026072921050875000_394.jul29_5.e100163.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.06.006"},{"key":"2026072921050875000_394.jul29_5.e100163.35","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0483-0"},{"key":"2026072921050875000_394.jul29_5.e100163.36","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1429"},{"key":"2026072921050875000_394.jul29_5.e100163.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.08.001"},{"key":"2026072921050875000_394.jul29_5.e100163.38","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.46"},{"key":"2026072921050875000_394.jul29_5.e100163.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.03.017"},{"key":"2026072921050875000_394.jul29_5.e100163.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2026072921050875000_394.jul29_5.e100163.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2022-111928"},{"key":"2026072921050875000_394.jul29_5.e100163.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3900"},{"key":"2026072921050875000_394.jul29_5.e100163.43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074495"},{"key":"2026072921050875000_394.jul29_5.e100163.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2025.08.097"},{"key":"2026072921050875000_394.jul29_5.e100163.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081165"},{"key":"2026072921050875000_394.jul29_5.e100163.46","unstructured":"Spineli L Brignardello-Petersen R Heen A . Obtaining absolute effect estimates to facilitate shared decision making in the context of multiple-treatment comparisons. Global Evidence Summit. Cape Town, 2017."},{"key":"2026072921050875000_394.jul29_5.e100163.47","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6381"},{"key":"2026072921050875000_394.jul29_5.e100163.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.08.012"},{"key":"2026072921050875000_394.jul29_5.e100163.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.10.014"},{"key":"2026072921050875000_394.jul29_5.e100163.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.01.011"},{"key":"2026072921050875000_394.jul29_5.e100163.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.06.010"},{"key":"2026072921050875000_394.jul29_5.e100163.52","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200077"},{"key":"2026072921050875000_394.jul29_5.e100163.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.06.017"},{"key":"2026072921050875000_394.jul29_5.e100163.54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1982.tb11683.x"},{"key":"2026072921050875000_394.jul29_5.e100163.55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb06271.x"},{"key":"2026072921050875000_394.jul29_5.e100163.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb08196.x"},{"key":"2026072921050875000_394.jul29_5.e100163.57","first-page":"485","article-title":"[On the efficacy of psychopharmaceutic agents in atopic neurodermatitis: comparative study of diazepam (Valium), promethazine (Phenergan) and placebo]","volume":"135","author":"Borelli","year":"1967","journal-title":"Dermatologica"},{"key":"2026072921050875000_394.jul29_5.e100163.58","first-page":"433","article-title":"Double-blind crossover trial with oral sodium cromoglycate in children with atopic dermatitis due to food allergy","volume":"57","author":"Businco","year":"1986","journal-title":"Ann Allergy"},{"key":"2026072921050875000_394.jul29_5.e100163.59","unstructured":"Cambazard F . Efficacy and safety of cetirizine drops at 3 doses (0.25, 0.50, 0.75 mg\/kg bw\/day) in an 8-week treatment of atopic dermatitis in 1 to 5 year old children: a multicentric, multi-country, double-blind, placebo-controlled, randomised study. 2001. Available at: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/viewArt45\/23741"},{"key":"2026072921050875000_394.jul29_5.e100163.60","first-page":"482","article-title":"Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream","volume":"85","author":"Chunharas","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"2026072921050875000_394.jul29_5.e100163.61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1984.tb00875.x"},{"key":"2026072921050875000_394.jul29_5.e100163.62","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.2002.01047.x"},{"key":"2026072921050875000_394.jul29_5.e100163.63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6666.96"},{"key":"2026072921050875000_394.jul29_5.e100163.64","first-page":"63","article-title":"Ketotifen in the treatment of atopic dermatitis. Results of a double blind study","volume":"15","author":"Falk","year":"1993","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"2026072921050875000_394.jul29_5.e100163.65","first-page":"629","article-title":"Analysis of the efficacy of mizolastine sustained release tablets combining with pevisone in treatment of perianal eczema","volume":"41","author":"Fan","year":"2012","journal-title":"J Clin Dermatol"},{"key":"2026072921050875000_394.jul29_5.e100163.66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1981.tb01600.x"},{"key":"2026072921050875000_394.jul29_5.e100163.67","doi-asserted-by":"publisher","DOI":"10.1007\/BF00412560"},{"key":"2026072921050875000_394.jul29_5.e100163.68","first-page":"365","article-title":"[Disodium cromoglycate in atopic dermatitis: double-blind therapeutic experience]","volume":"119","author":"Giannetti","year":"1984","journal-title":"G Ital Dermatol Venereol"},{"key":"2026072921050875000_394.jul29_5.e100163.69","first-page":"127","article-title":"Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults","volume":"70","author":"Hannuksela","year":"1993","journal-title":"Ann Allergy"},{"key":"2026072921050875000_394.jul29_5.e100163.70","first-page":"132","article-title":"[A double blind study of the effectiveness of ketotifen in preventing the development of asthma in atopic dermatitis patients]","volume":"40","author":"Iikura","year":"1991","journal-title":"Arerugi"},{"key":"2026072921050875000_394.jul29_5.e100163.71","first-page":"233","article-title":"Prevention of asthma by ketotifen in infants with atopic dermatitis","volume":"68","author":"Iikura","year":"1992","journal-title":"Ann Allergy"},{"key":"2026072921050875000_394.jul29_5.e100163.72","first-page":"77","article-title":"Clinical evaluation of E-0659 on atopic dermatitis. Multicenter double-blind study in comparison with ketotifen","volume":"17","author":"Ishibashi","year":"1989","journal-title":"Rinsho Hyoka"},{"key":"2026072921050875000_394.jul29_5.e100163.73","unstructured":"Jung EG Kaymer FK Ring J . Multicentre double-blind study in parallel groups, comparing to placebo 5 and 10 mg cetirizine administered in two daily doses for a week, to children aged 3-6 years suffering from atopic dermatitis\u2014determination of the antipruritic effect. 1989. Available at: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/viewArt45\/23764"},{"key":"2026072921050875000_394.jul29_5.e100163.74","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05293.x"},{"key":"2026072921050875000_394.jul29_5.e100163.75","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.73.278"},{"key":"2026072921050875000_394.jul29_5.e100163.76","first-page":"142","article-title":"A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis","volume":"44","author":"Klein","year":"1980","journal-title":"Ann Allergy"},{"key":"2026072921050875000_394.jul29_5.e100163.77","first-page":"117","article-title":"Double-blind study of cetirizine in atopic eczema in children","volume":"73","author":"La Rosa","year":"1994","journal-title":"Ann Allergy"},{"key":"2026072921050875000_394.jul29_5.e100163.78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1994.tb00768.x"},{"key":"2026072921050875000_394.jul29_5.e100163.79","first-page":"153","article-title":"Tolerance and efficacy of ketotifen in children with atopic dermatitis","volume":"33","author":"Leon","year":"1989","journal-title":"Dermatologia revista mexicana"},{"key":"2026072921050875000_394.jul29_5.e100163.80","first-page":"1196","article-title":"Comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of chronic allergic skin diseases in a pediatric population","volume":"43","author":"Lutsky","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"2026072921050875000_394.jul29_5.e100163.81","first-page":"17","article-title":"Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis","volume":"14","author":"Monroe","year":"1992","journal-title":"Clin Ther"},{"key":"2026072921050875000_394.jul29_5.e100163.82","doi-asserted-by":"publisher","DOI":"10.1159\/000063138"},{"key":"2026072921050875000_394.jul29_5.e100163.83","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.66.60"},{"key":"2026072921050875000_394.jul29_5.e100163.84","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.68.553"},{"key":"2026072921050875000_394.jul29_5.e100163.85","first-page":"235","article-title":"A double blind controlled trial of azatadine maleate syrup (idulamine syrup) in children with urticaria or atopic dermatitis. Comparison of effectiveness and side effect with d chlorpheniramine maleate syrup","volume":"8","author":"Nakayama","year":"1980","journal-title":"Rinsho hyoka: clinical evaluation"},{"key":"2026072921050875000_394.jul29_5.e100163.86","doi-asserted-by":"publisher","DOI":"10.3109\/09546639709160530"},{"key":"2026072921050875000_394.jul29_5.e100163.87","first-page":"148","article-title":"Clinical evaluation of cetirizine in the treatment of patients with urticaria and other skin diseases","volume":"12","author":"Ren","year":"1996","journal-title":"Chinese J Clin Pharmacol"},{"key":"2026072921050875000_394.jul29_5.e100163.88","first-page":"26","article-title":"Comparative clinical trial of embramine (mebryl)","volume":"41","author":"Satyanarayana","year":"1975","journal-title":"Indian J Dermatol Venerol Leprol"},{"key":"2026072921050875000_394.jul29_5.e100163.89","first-page":"440","article-title":"The clinical and immunological study of the mizolastine on the eczema and atopic dermatitis","volume":"38","author":"Sheng","year":"2009","journal-title":"J Clin Dermatol"},{"key":"2026072921050875000_394.jul29_5.e100163.90","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60662-X"},{"key":"2026072921050875000_394.jul29_5.e100163.91","first-page":"60","article-title":"Terfenadine versus ketotifene in children with atopic dermatitis","volume":"12","author":"Tholen","year":"1989","journal-title":"Allergologie"},{"key":"2026072921050875000_394.jul29_5.e100163.92","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2007.0098"},{"key":"2026072921050875000_394.jul29_5.e100163.93","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91363-7"},{"key":"2026072921050875000_394.jul29_5.e100163.94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb14732.x"},{"key":"2026072921050875000_394.jul29_5.e100163.95","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12630"},{"key":"2026072921050875000_394.jul29_5.e100163.96","first-page":"507","article-title":"Clinical evaluation of ketotifen syrup on atopic dermatitis: a comparative multicenter double-blind study of ketotifen and clemastine","volume":"62","author":"Yoshida","year":"1989","journal-title":"Ann Allergy"},{"key":"2026072921050875000_394.jul29_5.e100163.97","first-page":"7","article-title":"Comparative study of the effect of the hidroxicina the terfenadina and the astemizol in children with atopic demratitis: hospital General de Medellin-Centro de Especialistas cE.S. 1986-1988","volume":"3","author":"Zuluaga de Cadena","year":"1989","journal-title":"Revista CES medicina"},{"key":"2026072921050875000_394.jul29_5.e100163.98","unstructured":"Derm Research PLLC . Management of Pruritus With Xyzal in Atopic Dermatitis. (NCT00884325). 2013"},{"key":"2026072921050875000_394.jul29_5.e100163.99","unstructured":"Mitsubishi Tanabe Pharma Corporation . A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis. (NCT01840605). 2018"},{"key":"2026072921050875000_394.jul29_5.e100163.100","unstructured":"UCB Pharma . Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal\u00ae (Levocetirizine) vs Zyrtec\u00ae (Cetirizine) in Subjects With Dermatitis and Eczema. (NCT00375713). 2011"},{"key":"2026072921050875000_394.jul29_5.e100163.101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02719.x"},{"key":"2026072921050875000_394.jul29_5.e100163.102","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19457"},{"key":"2026072921050875000_394.jul29_5.e100163.103","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.12.1522"},{"key":"2026072921050875000_394.jul29_5.e100163.104","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12040"},{"key":"2026072921050875000_394.jul29_5.e100163.105","unstructured":"Skin Investigation Network of Canada. SkIN Canada Priority Setting Initiative 2022. https:\/\/skincanada.org\/priority-setting-initiative\/."},{"key":"2026072921050875000_394.jul29_5.e100163.106","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.13-RA-0675"},{"key":"2026072921050875000_394.jul29_5.e100163.107","doi-asserted-by":"publisher","DOI":"10.1186\/s40348-015-0027-1"},{"key":"2026072921050875000_394.jul29_5.e100163.108","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.499"},{"key":"2026072921050875000_394.jul29_5.e100163.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.07.019"},{"key":"2026072921050875000_394.jul29_5.e100163.110","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b19-00088"},{"key":"2026072921050875000_394.jul29_5.e100163.111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2015.02.009"},{"key":"2026072921050875000_394.jul29_5.e100163.112","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15239"},{"key":"2026072921050875000_394.jul29_5.e100163.113","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2021.33.4.351"},{"key":"2026072921050875000_394.jul29_5.e100163.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2025.01.003"},{"key":"2026072921050875000_394.jul29_5.e100163.115","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18345"},{"key":"2026072921050875000_394.jul29_5.e100163.116","unstructured":"National Institute for Health and Care Excellence. Atopic eczema in under 12s: diagnosis and management (clinical guideline CG57) 2025. Available from: https:\/\/www.nice.org.uk\/guidance\/cg57."},{"key":"2026072921050875000_394.jul29_5.e100163.117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.102"},{"key":"2026072921050875000_394.jul29_5.e100163.118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.09.020"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2026-100163","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2026-100163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:37:50Z","timestamp":1785436670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2026-100163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":118,"alternative-id":["10.1136\/bmj-2026-100163"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2026-100163","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}